Allmann, V., Dyntar, D., Lehnick, D., Dressler, M., Zeidler, K., Niederberger, P., Godau, J., Diebold, J., & Gautschi, O. (2023). Overall survival and role of programmed death ligand 1 expression in patients with metastatic non-small-cell lung cancer and immunotherapy: an observational study from central Switzerland. Swiss Medical Weekly, 153(1), 40039. https://doi.org/10.57187/smw.2023.40039